Acute SGLT2 Inhibition and the Pressure Natriuresis Response in Rats with Type 1 Diabetes

被引：0
|
作者：
Bailey, Matthew A.
Costello, Hannah M.
Stewart, Kevin
Binnie, David
Culshaw, Geoffrey C.
Webb, David J.
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
569.10
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes
    Huan Chen
    Yochai Birnbaum
    Regina Ye
    Hsiu-Chiung Yang
    Mandeep Bajaj
    Yumei Ye
    Cardiovascular Drugs and Therapy, 2022, 36 : 1091 - 1108
  • [22] Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Marc Evans
    Debbie Hicks
    Dipesh Patel
    Vinod Patel
    Phil McEwan
    Umesh Dashora
    Diabetes Therapy, 2020, 11 : 37 - 52
  • [23] Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus
    Rosa, Camila Moreno
    Salome Campos, Dijon Henrique
    Abreu Reyes, David Rafael
    Damatto, Felipe Cesar
    Kurosaki, Lucas Yamada
    Pagan, Luana Urbano
    Gomes, Mariana Janini
    Correa, Camila Renata
    Henrique Fernandes, Ana Angelica
    Okoshi, Marina Politi
    Okoshi, Katashi
    ANTIOXIDANTS, 2022, 11 (05)
  • [24] Response to the Letter on “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”
    Bertram Pitt
    Gabriel Steg
    Lawrence A. Leiter
    Deepak L. Bhatt
    Cardiovascular Drugs and Therapy, 2022, 36 : 573 - 573
  • [25] Effect of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, on Systolic Blood Pressure in Patients with Type 2 Diabetes
    Hardin, Marquette
    Davies, Michael
    Carroll, Amy
    Umpierrez, Guillermo
    CIRCULATION, 2024, 150
  • [26] Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes
    Ferrannini, E.
    Muscelli, E.
    Frascerra, S.
    Baldi, S.
    Mari, A.
    Heise, T.
    Broedl, U. C.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S372 - S373
  • [27] Effect of SGLT2 inhibition on coronary microvascular function in patients with type 2 diabetes
    Suhrs, H. E.
    Bove, K.
    Nilsson, M.
    Zander, M.
    Prescott, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2651 - 2651
  • [28] Alleviation of functional iron deficiency by SGLT2 inhibition in patients with type 2 diabetes
    Packer, Milton
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1143 - 1146
  • [29] Effects of SGLT2 inhibition on lipid transport in adipose tissue in type 2 diabetes
    Lauritsen, Katrine M.
    Voigt, Jens Hohwu
    Pedersen, Steen Bonlokke
    Hansen, Troels K.
    Moller, Niels
    Jessen, Niels
    Gormsen, Lars C.
    Sondergaard, Esben
    ENDOCRINE CONNECTIONS, 2022, 11 (04)
  • [30] Does SGLT2 Inhibition Affect Sympathetic Nerve Activity in Type 2 Diabetes?
    Dimova, Rumyana
    Tankova, Tsvetalina
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (02) : 75 - 84
12345